THMO vs. NTBL, WINT, CYCC, CNSP, SLRX, NAOV, NMRD, HSTO, RSLS, and NUWE
Should you be buying ThermoGenesis stock or one of its competitors? The main competitors of ThermoGenesis include Notable Labs (NTBL), Windtree Therapeutics (WINT), Cyclacel Pharmaceuticals (CYCC), CNS Pharmaceuticals (CNSP), Salarius Pharmaceuticals (SLRX), NanoVibronix (NAOV), Nemaura Medical (NMRD), Histogen (HSTO), ReShape Lifesciences (RSLS), and Nuwellis (NUWE). These companies are all part of the "medical" sector.
ThermoGenesis (NASDAQ:THMO) and Notable Labs (NASDAQ:NTBL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment and dividends.
Notable Labs has lower revenue, but higher earnings than ThermoGenesis.
5.8% of ThermoGenesis shares are owned by institutional investors. Comparatively, 70.5% of Notable Labs shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Comparatively, 1.2% of Notable Labs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
ThermoGenesis received 21 more outperform votes than Notable Labs when rated by MarketBeat users. However, 100.00% of users gave Notable Labs an outperform vote while only 60.47% of users gave ThermoGenesis an outperform vote.
Notable Labs has a net margin of 0.00% compared to ThermoGenesis' net margin of -148.15%. Notable Labs' return on equity of -62.07% beat ThermoGenesis' return on equity.
ThermoGenesis currently has a consensus target price of $5.00, indicating a potential upside of 654.60%. Notable Labs has a consensus target price of $8.00, indicating a potential upside of 716.33%. Given Notable Labs' higher probable upside, analysts clearly believe Notable Labs is more favorable than ThermoGenesis.
ThermoGenesis has a beta of 2.41, meaning that its stock price is 141% more volatile than the S&P 500. Comparatively, Notable Labs has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500.
In the previous week, Notable Labs had 5 more articles in the media than ThermoGenesis. MarketBeat recorded 6 mentions for Notable Labs and 1 mentions for ThermoGenesis. Notable Labs' average media sentiment score of 0.04 beat ThermoGenesis' score of -0.95 indicating that Notable Labs is being referred to more favorably in the news media.
Summary
Notable Labs beats ThermoGenesis on 11 of the 15 factors compared between the two stocks.
Get ThermoGenesis News Delivered to You Automatically
Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding THMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ThermoGenesis Competitors List
Related Companies and Tools